• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problems Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583); Device Dislodged or Dislocated (2923)
Patient Problems Aortic Insufficiency (1715); Complete Heart Block (2627)
Event Type  Injury  
Event Description
The manufacturer was notified on oct 28, 2016 of the following from a scientific paper: during the postoperative course, he patient experienced total av block, requiring pacemaker implantation.At discharge, tte showed a trace of pvl.The patient missed their follow-up appointment and was readmitted 15 months later with congestive heart failure.The tte showed severe pvl caused by distorted and displaced valve.Reoperation was performed via median sternotomy and the valve was explanted with no signs of infection or deterioration.After complete calcium debridement, the appropriate perceval sizing was one size larger than at first operation.A trifecta 23 mm was then implanted and the postoperative course was uneventful.
 
Manufacturer Narrative
Additional information was requested to the hospital.However, no further information including the device serial number was able to be obtained.Therefore, based on the limited information provided no conclusion can be drawn for this event.
 
Event Description
This is a case report where the authors speculate that an initial undersize was the cause for a late migration (even though they replaced the perceval m with a trifecta 23!), thus they warn the reader of the importance of a careful sizing after calcium debridement.The stent of the valve appears quite deformed, thus i am wondering if the migration was due to a patient anatomic feature (eg.Hypertrophic septum causing instability and later dislodgment?).Authors: gilles amr, md, msc1; aly ghoneim, md1; geneviève giraldeau, md2; philippe demers, md, msc, frcsc1.- from the department of cardiac surgery, montreal heart institute, montréal, québec, canada; and the department of cardiology, montreal heart institute, montréal, québec, canada.Central message: we report the first case of a delayed proximal migration of a perceval bioprosthesis 15 months after implantation.Postoperative course - total av block, requiring pacemaker implantation.At discharge, tte showed a trace of pvl.The patient missed follow-up appointment and was readmitted 15 months later with congestive heart failure.The tte showed severe pvl caused by distorted and displaced valve.Reoperation via median sternotomy.Valve was explanted with no signs of infection or deterioration.After complete calcium debridement, the appropriate perceval sizing was one size larger than at first operation.A trifecta 23 mm was then used.The postoperative course was uneventful.Update 21st jun: r.Gordan -no more info received after several attempts at follow up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
4125650
MDR Report Key6127477
MDR Text Key60875748
Report Number3004478276-2016-00156
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,litera
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/28/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/25/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVS23
Device Catalogue NumberICV1209
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-